Nanotechnology, Messenger RNA Combination: New COVID-19 Treatment

In mouse model researchers have prompted the production of a protein that can block multiple variants of the SARS-CoV-2 virus from entering cells and causing disease.

Messenger RNA and nanotechnology combination is a proof of principle for a new “universal” means of treating COVID-19.

“Rather than messenger RNA as a vaccine, this shows that mRNA can be used as a universal therapy against different coronaviruses,” Sahay said. “Despite mass vaccination, there is an urgent need to develop effective treatment options to end this pandemic. Several therapies have shown some effectiveness, but the virus’ high mutation rate complicates the development of drugs that treat all variants of concern.”

New COVID-19 Treatment

Findings were published in ACS Nano. Next steps involve showing that the protein prevents infection in mice, said Sahay, who added that the mRNA treatment is possibly “a couple of years” away from being available to human patients.

Use of Nanotechnology in Healthcare - Brain, Breast, Dental, Orthopedic, Ocular
Nanotechnology provides several potential solutions for many life-threatening diseases. Learn more about the role of nanotechnology in healthcare

‘'Decoy' enzyme that binds to corona virus spike protein can be produced by using mRNA packaged in lipid nanoparticles as shown in mouse model’

Breathing in the virus is the primary way to contract COVID-19, blamed for 6 million deaths globally since the pandemic began in late 2019. The virus’ envelope is covered in spike proteins that bind to an enzyme produced by cells in the lungs.

The study, which involved messenger RNA that was administered intravenously and also through inhalation, which would be the preferred delivery method for humans, was published in Advanced Science.

“Proteins are large, complex molecules that serve as the workhorses of cells, enabling all of the biological functions within a cell,” said Sahay, an associate professor in the OSU College of Pharmacy. “DNA holds the blueprints from which proteins get made after the code is first transcribed into messenger RNA.”

Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.

With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.

An enzyme is a type of protein that acts as a catalyst for biochemical reactions. HACE2 – short for human angiotensin-converting enzyme 2 – is an enzyme of the airway cells. It is also expressed in the heart, kidney and intestine, and has a hand in numerous physiological functions. Simply giving a COVID-19 patient hACE2 would have limited effectiveness in treating the disease, Sahay said, because the soluble form of the enzyme, the kind that can circulate throughout the body, has a short half-life – less than two hours, meaning it wouldn’t stay in a person’s system very long.

Can Long COVID-19 be Blamed for Feeling Breathless After Exercising
Feeling out of Breath while exercising after COVID-19? It could be a symptom of Long COVID that decreases heart rate and oxygen concentration during exercise.

But lipid nanoparticles, often abbreviated to LNP, containing mRNA that orders production of the enzyme can help overcome that problem.

Nanoparticles and Treatment of COVID-19

In this study, the researchers engineered synthetic mRNA to encode a soluble form of the enzyme, packaged the mRNA into lipid nanoparticles and delivered it to cells in the liver with an IV; within two hours, the enzyme was in the mice’s bloodstream, and it stayed there for days.

The scientists also delivered the loaded LNP via inhalation, prompting epithelial cells in the lungs to secrete soluble hACE2.

Long COVID-19 Haulers Should Take Precaution in Polluted Air
Exposure to air pollution increases the likelihood of hospitalization by 30% in people who suffer from long COVID-19.

“The soluble enzyme effectively inhibited live SARS-CoV-2 from infecting host cells,” said OSU postdoctoral researcher Jeonghwan Kim. “The synthesis of mRNA is fast, affordable and scalable, and LNP-delivered mRNA can be repeated as necessary to sustain protein production until the infection subsides. Once treatment stops, the no-longer-needed soluble hACE2 clears the system in a matter of days.”

In addition to Sahay, other Oregon State scientists contributing to the research were Jeonghwan Kim, Antony Jozic, Anindit Mukherjee and Dylan Nelson. The studies with the live virus were performed in collaboration with Texas Biomedical Research Institute scientists Kevin Chiem, Md Siddiqur Rahman Khan Jordi B. Torrelles, and Luis Martinez-Sobrido.

Funding from the OSU College of Pharmacy supported this study. Sahay lab is supported through funding from NIH and Cystic Fibrosis Foundation.

Source-Eurekalert